Articles

An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 20-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached more than 300 million children—a turning point in the battle to protect people from this dreaded disease.

Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC, an all-in-one self-injectable contraceptive that puts women in charge of their reproductive health.

Low-cost, simple, point-of-care blood tests for G6PD enzyme deficiency are a key part of Plasmodium vivax malaria treatment, and a step towards eliminating malaria overall